Hyperalgesia due to nerve injury: Role of prostaglandins

Neuroscience

Volumn 94, Issue 2, 1999, Pages 587-594

  Syriatowicz, J P ^a   Hu, D ^a   Walker, J S ^a   Tracey, D J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cyclo oxygenase; Hyperalgesia; Indomethacin; Meloxicam; Peripheral neuropathy

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERALGESIA; MALE; NERVE INJURY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CYCLOOXYGENASE INHIBITORS; FUNCTIONAL LATERALITY; HINDLIMB; HYPERALGESIA; INDOMETHACIN; MALE; PROSTAGLANDINS; PYRAZOLES; RATS; RATS, WISTAR; SCIATIC NERVE; THIAZINES; THIAZOLES; TIME FACTORS;

EID: 0032884345     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00365-6     Document Type: Article

References (84)

1. Aeberhard E.E., Henderson S.A., Arabolos N.S., Griscavage J.M., Castro F.E., Barrett C.T., Ignarro L.J. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem. biophys. Res. Commun. 208:1995;1053-1059.
2. Attal N., Jazat F., Kayser V., Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain. 41:1990;235-251.
3. Bhattacharyya D.K., Lecomte M., Dunn J., Morgans D.J., Smith W.L. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid. Archs Biochem. Biophys. 317:1995;19-24.
4. 2-induced activation and sensitization of articular mechanonociceptors. Neurosci. Lett. 124:1991;5-8.
5. Bley K.R., Hunter J.C., Eglen R.M., Smith J.A. The role of IP prostanoid receptors in inflammatory pain. Trends pharmac. Sci. 19:1998;141-147.
6. Brooks P.M., Day R.O. Nonsteroidal antiinflammatory drugs - differences and similarities. New Engl. J. Med. 324:1991;1716-1725.
7. Carstens E. Neural mechanisms of hyperalgesia: peripheral or central sensitization? News physiol. Sci. 10:1995;260-265.
8. Cervero F. Spinal cord mechanisms of hyperalgesia and allodynia: role of peripheral input from nociceptors. Prog. Brain Res. 113:1996;413-422.
9. Clatworthy A.L., Illich P.A., Castro G.A., Walters E.T. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184:1995;5-8.
10. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmac. Rev. 46:1994;205-229.
11. Constable A.L., Armati P.J., Toyka K.V., Hartung H.-P. Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res. 635:1994;75-80.
12. De Benedittis G., Besana F., Lorenzetti A. A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial. Pain. 48:1992;383-390.
13. Diamond A. W. and Coniam S. W. (1991) The Management of Chronic Pain, pp. 101-110. Oxford University Press, Oxford.
14. Enerbäck L., Olsson Y., Sourander P. Mast cells in normal and sectioned peripheral nerve. Z. Zellforsch. 66:1965;596-608.
15. Farah B.A. Ketorolac in reflex sympathetic dystrophy. Clin. Neuropharmac. 16:1993;88-89.
16. Fields H. L. (1994) Peripheral neuropathic pains: an approach to management. In Textbook of Pain (eds Wall P. D. and Melzack R.), pp. 991-996. Churchill Livingstone, Edinburgh.
17. Frisen J., Risling M., Fried K. Distribution and axonal relations of macrophages in a neuroma. Neuroscience. 55:1993;1003-1013.
18. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 47:1994;55-59.
19. Goff J.R., Burkey A.R., Goff D.J., Jasmin L. Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience. 82:1998;559-574.
20. Grossman C.J., Wiseman J., Lucas F.S., Trevethick M.A., Birch P.J. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm. Res. 44:1995;253-257.
21. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
22. Heywood G., Ansselin A., Tracey D.J. Adult Schwann cells release prostaglandins in vitro. Proc. Aust. Neurosci. Soc. 7:1996;233.
23. Holthusen H., Arndt J.O. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci. Lett. 165:1994;71-74.
24. Hong Y., Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience. 63:1994;827-836.
25. Keita H., Kayser V., Guilbaud G. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. Eur. J. Pharmac. 277:1995;275-280.
26. Khasar S.G., Green P.G., Levine J.D. Comparison of intradermal and subcutaneous hyperalgesic effects of inflammatory mediators in the rat. Neurosci. Lett. 153:1993;215-218.
27. Khasar S.G., Ho T., Green P.G., Levine J.D. Comparison of prostaglandin E1- and prostaglandin E2-induced hyperalgesia in the rat. Neuroscience. 62:1994;345-350.
28. Khasar S.G., Ouseph A.K., Chou B., Ho T., Green P.G., Levine J.D. Is there more than one prostaglandin E receptor subtype mediating hyperalgesia in the rat hindpaw? Neuroscience. 64:1995;1161-1165.
29. King R.B. Concerning the management of pain associated with herpes zoster and of postherpetic neuralgia. Pain. 33:1988;73-78.
30. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-139.
31. Kress M. and Reeh P. W. (1996) Chemical excitation and sensitization in nociceptors. In Neurobiology of Nociceptors (eds Belmonte C. and Cervero F.), pp. 258-297. Oxford University Press, Oxford.
32. Kumazawa T., Mizumura K., Koda H. Involvement of EP3 subtype of prostaglandin E receptors in PGE2-induced enhancement of the bradykinin response of nociceptors. Brain Res. 632:1993;321-324.
33. Kumazawa T., Mizumura K., Koda H. Possible involvement of the EP2 receptor subtype in PGE2-induced enhancement of the heat response of nociceptors. Neurosci. Lett. 175:1994;71-73.
34. Laird J.M.A., Bennett G.J. An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J. Neurophysiol. 69:1993;2072-2085.
35. Levine J. and Taiwo Y. (1994) Inflammatory pain. In Textbook of Pain (eds Wall P. D. and Melzack R.), pp. 45-56. Churchill Livingstone, Edinburgh.
36. Levine J.D., Coderre T.J., White D.M., Finkbeiner W.E., Basbaum A.I. Denervation-induced inflammation in the rat. Neurosci. Lett. 119:1990;37-40.
37. Levine J.D., Gooding J., Donatoni P., Borden L., Goetzl E.J. The role of the polymorphonuclear leukocyte in hyperalgesia. J. Neurosci. 5:1985;3025-3029.
38. Maloney C.G., Kutchera W.A., Albertine K.H., McIntyre T.M., Prescott S.M., Zimmerman G.A. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J. Immun. 160:1998;1402-1410.
39. Marshall J.S., Gomi K., Blennerhassett M.G., Bienenstock J. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J. Immun. 162:1999;4271-4276.
40. McMahon S.B., Priestley J.V. Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives. Curr. Opin. Neurobiol. 5:1995;616-624.
41. Metzler C.M., Elfring G.L., McEwen A.J. A user's manual for NONLIN and associated programs. Biometrics. 30:1974;562.
42. Meyer R.A., Campbell J.N. Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand. Science. 213:1981;1527-1529.
43. Minakami K., Watanabe Y., Miyahara M., Kobuchi H., Kurashige T., Utsumi K. Effect of indomethacin and aspirin on the TNF-alpha-induced priming and protein tyrosyl phosphorylation of human neutrophils. Physiol. Chem. Phys. Med. NMR. 25:1993;55-67.
44. Mizumura K., Kumazawa T. Modification of nociceptor responses by inflammatory mediators and second messengers implicated in their action - a study in canine testicular polymodal receptors. Prog. Brain Res. 113:1996;115-141.
45. Nathan C.F. Secretory products of macrophages. J. clin. Invest. 79:1987;319-326.
46. Ouellet M., Percival M.D. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem. J. 306:1995;247-251.
47. Pairet M., Van Ryn J., Schierok H., Mauz A., Trummlitz G., Engelhardt G. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′ isomer. Inflamm. Res. 47:1998;270-276.
48. Pateromichelakis S., Rood J.P. Prostaglandin E1-induced sensitization of A delta moderate pressure mechanoreceptors. Brain Res. 232:1982;89-96.
49. Perry V. H. (1994) Macrophages and the Nervous System, p. 123. R. G. Landes, Austin, TX.
50. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Archs int. Pharmacodyn. 111:1957;409-419.
51. Rang H.P., Bevan S., Dray A. Chemical activation of nociceptive peripheral neurones. Br. med. Bull. 47:1991;534-548.
52. Reddy S.T., Winstead M.V., Tischfield J.A., Herschman H.R. Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells. J. biol. Chem. 272:1997;13,591-13,596.
53. Ro L.-S., Chen S.-T., Tang L.-M., Jacobs J.M. Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain. 79:1999;265-274.
54. Ro L.-S., Jacobs J.M. The role of the saphenous nerve in experimental sciatic nerve mononeuropathy produced by loose ligatures: a behavioural study. Pain. 52:1993;359-369.
55. Sanner J.H. Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz(b,f)(1,4)oxazepine-10-carbonyl) hydrazine (SC-19220). Archs int. Pharmacodyn. Thér. 180:1969;46-56.
56. 2. J. Physiol., Lond. 403:1988;91-104.
57. Schmauder-Chock E.A., Chock S.P. Localization of cyclo-oxygenase and prostaglandin E2 in the secretory granule of the mast cell. J. Histochem. Cytochem. 37:1989;1319-1328.
58. Schmelz M., Kress M. Topical acetylsalicylate attenuates capsaicin induced pain, flare and allodynia but not thermal hyperalgesia. Neurosci. Lett. 214:1996;72-74.
59. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. natn. Acad. Sci. U.S.A. 91:1994;12,013-12,017.
60. Seltzer Z. The relevance of animal neuropathy models for chronic pain in humans. Semin. Neurosci. 7:1995;211-219.
61. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
62. Shir Y., Seltzer Z. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci. Lett. 115:1990;62-67.
63. Simone D.A. Neural mechanisms of hyperalgesia. Curr. Opin. Neurobiol. 2:1992;479-483.
64. Smith W.L., Meade E.A., DeWitt D.L. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann. N. Y. Acad. Sci. 744:1994;50-57.
65. Sommer C., Lalonde A., Heckman H.M., Rodriguez M., Myers R.R. Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J. Neuropath. exp. Neurol. 54:1995;635-643.
66. Sorkin L.S., Xiao W.H., Wagner R., Myers R.R. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience. 81:1997;255-562.
67. Syriatowicz J.-P., Tracey D.J. Hyperalgesia due to nerve damage: role of prostaglandins. Proc. Aust. Neurosci. Soc. 7:1996;100.
68. Syriatowicz J.-P. and Tracey D. J. (1996) Prostaglandins contribute to peripheral hyperalgesia in a rat model of nerve injury. Abstracts 8th World Congress on Pain, p. 353.
69. Taiwo Y.O., Coderre T.J., Levine J.D. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res. 487:1989;148-151.
70. Taiwo Y.O., Goetzl E.J., Levine J.D. Hyperalgesia onset latency suggests a hierarchy of action. Brain Res. 423:1987;333-337.
71. Taiwo Y.O., Levine J.D. Indomethacin blocks central nociceptive effects of PGF2 alpha. Brain Res. 373:1986;81-84.
72. Taiwo Y.O., Levine J.D. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Res. 537:1990;372-374.
73. Taiwo Y.O., Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience. 48:1992;485-490.
74. Tharion G., Bhattacharji S. Aspirin in chloroform as an effective adjuvant in the management of chronic neurogenic pain. Archs phys. med. Rehabil. 78:1997;437-439.
75. Theodosiou M., Rush R.A., Zhou X.-F., Hu D., Walker J.S., Tracey D.J. Hyperalgesia due to nerve damage - role of nerve growth factor. Pain. 81:1999;245-255.
76. Tracey D.J., Cunningham J.E., Romm M.A. Peripheral hyperalgesia in experimental neuropathy: mediation by α2 adrenoreceptors on postganglionic sympathetic terminals. Pain. 60:1995;317-327.
77. Tracey D.J., Romm M.A., Yao N.N.L. Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y. Brain Res. 669:1995;245-254.
78. Tracey D.J., Walker J.S. Pain due to nerve damage: are inflammatory mediators involved? Inflamm. Res. 44:1995;407-411.
79. Treede R.-D., Meyer R.A., Raja S.N., Campbell J.N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol. 38:1992;397-421.
80. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. A. Rev. Pharmac. Toxic. 38:1998;97-120.
81. Vanos D.N., Ramamurthy S., Hoffman J. Intravenous regional block using ketorolac: preliminary results in the treatment of reflex sympathetic dystrophy. Anesth. Analg. 74:1992;139-141.
82. Wagner R., Janjigian M., Myers R.R. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain. 74:1998;35-42.
83. Willingale H.L., Gardiner N.J., McLymont N., Giblett S., Grubb B.D. Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br. J. Pharmac. 122:1997;1593-1604.
84. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.